Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00041314 · ClinicalTrials.gov registry record · Phase 2

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

A Phase 2 study of Lung Cancer, sponsored by Eastern Cooperative Oncology Group.

Completed
Registry status
Phase 2
Development phase
20
Study locations

NCT00041314: Completed Phase 2 study of Lung Cancer, sponsored by Eastern Cooperative Oncology Group.

NCT00041314 is a Phase 2 study of Lung Cancer that has completed, run by Eastern Cooperative Oncology Group. The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00041314, a Phase 2 study of Lung Cancer, has completed, sponsored by Eastern Cooperative Oncology Group.

COMPLETED
Registry status
Phase 2
Development phase
20
Study locations

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of carboplatin, gemcitabine, and exisulind in treating patients who have advanced non-small cell lung cancer.

Conditions Studied

Lung Cancer

Interventions

  • DRUG carboplatin
  • DRUG gemcitabine hydrochloride
  • DRUG exisulind

Study Locations (20)

Illinois

  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University - Chicago
  • Veterans Affairs Medical Center - Lakeside Chicago - Chicago
  • CCOP - Central Illinois - Decatur
  • CCOP - Evanston - Evanston
  • Evanston Northwestern Health Care - Evanston
  • CCOP - Illinois Oncology Research Association - Peoria

Florida

  • Veterans Affairs Medical Center - Gainesville - Gainesville
  • Veterans Affairs Medical Center - Miami - Miami
  • H. Lee Moffitt Cancer Center and Research Institute - Tampa
  • Veterans Affairs Medical Center - Tampa (Haley) - Tampa

California

  • City of Hope Comprehensive Cancer Center - Duarte
  • Veterans Affairs Medical Center - Palo Alto - Palo Alto
  • Stanford University Medical Center - Stanford

Georgia

  • Emory University Hospital - Atlanta - Atlanta
  • Veterans Affairs Medical Center - Atlanta (Decatur) - Decatur

Alabama

  • University of Alabama at Birmingham Comprehensive Cancer Center - Birmingham

Arizona

  • CCOP - Scottsdale Oncology Program - Scottsdale

Colorado

  • CCOP - Colorado Cancer Research Program, Inc. - Denver

Delaware

  • CCOP - Christiana Care Health Services - Wilmington

Trial Details

FieldValue
Start Date 2002-10-04
Est. Completion 2007-06-15
Phase Phase 2
Eastern Cooperative Oncology Group

141 total trials

What the finished NCT00041314 record still lists

NCT00041314 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which carboplatin is the first listed.

NCT00041314 names 20 study sites across 9 states, led by Illinois, Florida, California.

Frequently Asked Questions

What is clinical trial NCT00041314 about?

NCT00041314 is a clinical study titled "Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of carboplatin, gemcitabine, and exisulind in treating patients who have...

What is the current status of trial NCT00041314?

This trial is currently completed. It is a Phase 2 study. The study started on 2002-10-04. Estimated completion is 2007-06-15.

What conditions does trial NCT00041314 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00041314?

The interventions under investigation include: carboplatin (DRUG), gemcitabine hydrochloride (DRUG), exisulind (DRUG).

Who is sponsoring clinical trial NCT00041314?

This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00041314 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT00041314, the US trial registry maintained by the National Library of Medicine. NCT00041314 (unsized enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.